Vistin Pharma ASA (VISTN)

Currency in NOK
19.00
-0.50(-2.56%)
Closed·
High dividend Yield
VISTN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.5519.00
52 wk Range
17.7023.50
Key Statistics
Prev. Close
19
Open
19
Day's Range
18.55-19
52 wk Range
17.7-23.5
Volume
11.24K
Average Volume (3m)
9.59K
1-Year Change
-6.4039%
Book Value / Share
7.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VISTN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Vistin Pharma ASA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Vistin Pharma ASA Earnings Call Summary for Q3/2026

  • Q3 revenue flat at NOK 108.4M while sales volume hit record 1,610 tons; EBITDA fell 32% to NOK 19M on higher raw material costs.
  • Gross margin dropped to 57% from elevated input costs during Hormuz disruption; management expects recovery above 60% in Q4.
  • Four-week October maintenance stop will cut Q4 output by one-third, significantly impacting near-term results.
  • Company targets 7,000 metric tons annual output through process optimization; commercializing Direct Compressible product at 800 tons.
  • Stock down 1.4% to $18, near 52-week low; trades at 11.5x P/E with 5.5% dividend yield despite margin pressures.
Last Updated: 2026-10-29, 04:12 a/m
Read Full Transcript

Earnings

Latest Release
Oct 29, 2026
EPS / Forecast
0.25 / --
Revenue / Forecast
108.39M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.41
Dividend Yield
7.89%
Industry Median 8.15%
Annualized payout
1.50
Paid unevenly
5-Years Growth
+24.57%
Growth Streak

VISTN Income Statement

Compare VISTN to Peers and Sector

Metrics to compare
VISTN
Peers
Sector
Relationship
P/E Ratio
13.4x13.9x−0.2x
PEG Ratio
−0.680.010.00
Price/Book
2.5x1.0x2.6x
Price / LTM Sales
1.9x1.3x2.6x
Upside (Analyst Target)
-47.3%76.9%
Fair Value Upside
Unlock23.8%14.9%Unlock

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets. The company was founded in 1969 and is based in Oslo, Norway.

Employees
76
Market
Norway

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.37M9.86%84.15M
Other Institutional Investors
13.28M29.94%255.61M
Public Companies & Retail Investors
26.69M60.20%513.88M
Total
44.34M100.00%853.63M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Holmen Fondsforvaltning Ltd.9.86%4,371,55884,152
Holmen Spesialfond9.86%4,371,55884,152

People Also Watch

9.80
SAMPO
0.00%
21.18
UPM
-1.35%
4.588
MOTA
-2.38%
165.4
TRYG
+0.92%
481
RBREW
-0.41%

FAQ

What Is the Vistin Pharma ASA (VISTN) Stock Price Today?

The Vistin Pharma ASA stock price today is 19.00 NOK.

What Stock Exchange Does Vistin Pharma ASA Trade On?

Vistin Pharma ASA is listed and trades on the Oslo Stock Exchange.

What Is the Stock Symbol for Vistin Pharma ASA?

The stock symbol for Vistin Pharma ASA is "VISTN."

Does Vistin Pharma ASA Pay Dividends? What’s The Current Dividend Yield?

The Vistin Pharma ASA dividend yield is 7.9%%.

What Is the Vistin Pharma ASA Market Cap?

As of today, Vistin Pharma ASA market cap is 842.55M NOK.

What Is Vistin Pharma ASA's Earnings Per Share (TTM)?

The Vistin Pharma ASA EPS (TTM) is 1.41.

From a Technical Analysis Perspective, Is VISTN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Vistin Pharma ASA Stock Split?

Vistin Pharma ASA has split 1 times.

How Many Employees Does Vistin Pharma ASA Have?

Vistin Pharma ASA has 76 employees.

What is the current trading status of Vistin Pharma ASA (VISTN)?

As of Nov 21, 2026, Vistin Pharma ASA (VISTN) is trading at a price of 19.00 NOK, with a previous close of 19.00 NOK. The stock has fluctuated within a day range of 18.55 NOK to 19.00 NOK, while its 52-week range spans from 17.70 NOK to 23.50 NOK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.